Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas
SUIT-SAVM
1 other identifier
observational
380
1 country
1
Brief Summary
Spinal arteriovenous fistulas (AVFs) and arteriovenous malformations (AVMs) are complex neurosurgical lesions that are very challenging to manage. Spinal vascular malformations account for 3%-4% of all intradural spinal cord mass lesions. Over the last few decades our understanding of these lesions has dramatically increased thanks to neuroimaging technology (e.g. spinal angiography and indocyanine green angiography). Various treatment modalities including conservative observation, endovascular embolization, microsurgical resection, radiation therapy, and combined therapies have been reported. The treatment for these AVMs and AVFs depends on their location, the type of malformation, the area of the spine involved, and the condition of the patient at the time of treatment. Due to the rarity of these spinal vascular lesions, reports of their management and outcomes have been limited to small series and case reports. And the rates of obliteration and outcomes are not satisfactory, especially the spinal AVMs. Spinal vascular lesions are rare but represent a formidable challenge for the treating neurosurgeon.The purpose of this study is to establish multimodality treatment mode and evaluate the anatomical cure rate and functional preservation rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 27, 2016
CompletedFirst Posted
Study publicly available on registry
January 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJune 6, 2017
June 1, 2017
2.1 years
December 27, 2016
June 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of the spinal cord function
American Spinal Injury Association(ASIA) Score for evaluating the spinal cord function.Indexes (ASIA score) at baseline (1 day before operation) and 12 months follow-up will be collected, then the change from preoperative to 12 months follow-up will be assessed.
1 day before operation and 12 months postoperative
Secondary Outcomes (5)
Anatomic obliteration rate
3 months post operation
American Spinal Injury Association(ASIA) Score
1 week, 3 months, 6 months, 12 months post operation
Modified Aminoff & Logue's Scale (mALS)
1 week, 3 months, 6 months, 12 months post operation
Modified Denis Pain and Numbness Scale (mDPNS)
1 week, 3 months, 6 months, 12 months post operation
Incidence of perioperative complications
1 week
Eligibility Criteria
patients with spinal AVMs/AVFs
You may qualify if:
- patient diagnosed with spinal vascular diseases including
- intradural arteriovenous malformation,
- intradural arteriovenous fistula,
- dural arteriovenous fistula,
- extradural arteriovenous malformation,
- paravertebral arteriovenous malformation,
- paravertebral arteriovenous fistula,
- cobbs' syndrome,
- other spinal arteriovenous metameric syndromes involve the spinal cord.
- patient not received surgical or interventional treatment before
- patient with normal cardiac, renal and hepatic function
- patient capable of understanding the content of the patient information / Informed Consent Form
- patient willing and able to participate in the registry
You may not qualify if:
- patient received surgical treatment or interventional treatment before
- patient is pregnant
- patient allergic to iodine
- patient unable to complete follow-up
- patient with cerebral lesions
- patient with other spinal lesions
- patient with cardiac, renal or hepatic dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hongqi Zhang, MDlead
- Beijing Tiantan Hospitalcollaborator
- Beijing Tsinghua Chang Gung Hospitalcollaborator
- Tianjin Medical University General Hospitalcollaborator
- Peking University Third Hospitalcollaborator
- Chinese PLA General Hospitalcollaborator
- Beijing Hospitalcollaborator
- General Hospital of Chinese Armed Police Forcescollaborator
- Beijing Haidian Hospitalcollaborator
- China Rehabilitation Research Centercollaborator
Study Sites (1)
Tao Hong
Beijing, China
Related Publications (4)
Lee YJ, Terbrugge KG, Saliou G, Krings T. Clinical features and outcomes of spinal cord arteriovenous malformations: comparison between nidus and fistulous types. Stroke. 2014 Sep;45(9):2606-12. doi: 10.1161/STROKEAHA.114.006087. Epub 2014 Jul 15.
PMID: 25028446BACKGROUNDRangel-Castilla L, Russin JJ, Zaidi HA, Martinez-Del-Campo E, Park MS, Albuquerque FC, McDougall CG, Nakaji P, Spetzler RF. Contemporary management of spinal AVFs and AVMs: lessons learned from 110 cases. Neurosurg Focus. 2014 Sep;37(3):E14. doi: 10.3171/2014.7.FOCUS14236.
PMID: 25175433BACKGROUNDGross BA, Du R. Spinal glomus (type II) arteriovenous malformations: a pooled analysis of hemorrhage risk and results of intervention. Neurosurgery. 2013 Jan;72(1):25-32; discussion 32. doi: 10.1227/NEU.0b013e318276b5d3.
PMID: 23096418BACKGROUNDGross BA, Du R. Spinal pial (type IV) arteriovenous fistulae: a systematic pooled analysis of demographics, hemorrhage risk, and treatment results. Neurosurgery. 2013 Jul;73(1):141-51; discussion 151. doi: 10.1227/01.neu.0000429848.91707.73.
PMID: 23615108BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zhang Hongqi, MD
Neurosurgical Department, Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Neurosurgery
Study Record Dates
First Submitted
December 27, 2016
First Posted
January 19, 2017
Study Start
December 1, 2016
Primary Completion
December 31, 2018
Study Completion
December 31, 2019
Last Updated
June 6, 2017
Record last verified: 2017-06